NCT06741644 2026-04-15
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
CStone Pharmaceuticals
Phase 1/2 Recruiting
CStone Pharmaceuticals
HC Biopharma Inc.
Shanghai Hengrui Pharmaceutical Co., Ltd.
BeiGene
EMD Serono
Shanghai Runshi Pharmaceutical Technology Co., Ltd
EMD Serono
GlaxoSmithKline